Idorsia Ltd
About
Idorsia Ltd (SW:IDIA) — investor relations, events, news, and company updates on 6ix.
Latest News
Today
Idorsia reports strong Q1 2026 performance with 74% QUVIVIQ sales growth year-on-year
Apr 10 2026
Idorsia issues invitation to the 2026 Annual General Meeting of Shareholders
Apr 9 2026
Idorsia welcomes Amer Joseph as new Chief Medical Officer and Head of Global Clinical Development
Mar 30 2026
Idorsia’s daridorexant delivers outstanding results in a Phase 2 study in children with insomnia disorder
Mar 24 2026
Idorsia announces the nomination of three candidates for election to the Board of Directors
Financials
Revenue
CHF220.58 M
Market Cap
CHF887.4 M
EPS
-0.52